Keltic Pharma Therapeutics jobs and careers

Ireland

About Keltic Pharma Therapeutics

In 2019 Prof Andrew Tobin published validation of PfCLK3 as a target with breakthrough potential in the treatment of malaria. Successful drug development would provide a single medicine that is curative, transmission blocking and prophylactic.

Employees: 1 to 10
Headquarters: Ireland

Leadership

The top of Keltic Pharma Therapeutics's org chart, with how many people report into each leader.

Andrew Tobin

Chief Executive Officer and Founder

Jobs at Keltic Pharma Therapeutics

No open positions right now. Explore more companies on TheJobsMap.